20-45890601-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_080749.4(NEURL2):āc.391G>Cā(p.Glu131Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000229 in 1,612,432 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_080749.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NEURL2 | NM_080749.4 | c.391G>C | p.Glu131Gln | missense_variant | 1/2 | ENST00000372518.5 | |
NEURL2 | NM_001278535.2 | c.391G>C | p.Glu131Gln | missense_variant | 1/2 | ||
SPATA25 | XM_024451826.2 | c.-2173G>C | 5_prime_UTR_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NEURL2 | ENST00000372518.5 | c.391G>C | p.Glu131Gln | missense_variant | 1/2 | 1 | NM_080749.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152226Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000286 AC: 7AN: 244596Hom.: 0 AF XY: 0.00000749 AC XY: 1AN XY: 133552
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1460206Hom.: 0 Cov.: 37 AF XY: 0.0000289 AC XY: 21AN XY: 726336
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152226Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2024 | The c.391G>C (p.E131Q) alteration is located in exon 1 (coding exon 1) of the NEURL2 gene. This alteration results from a G to C substitution at nucleotide position 391, causing the glutamic acid (E) at amino acid position 131 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at